Von dem Buch Benign Prostatic Hyperplasia: Conservative and Operative Management haben wir 4 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Gerhard Jakse (Editor), Jean de Leval (Editor), Christian Bouffioux (Editor), Rudi A. Janknegt (Editor): Benign Prostatic Hyperplasia: Conservative and Operative Management (ISBN: 9783642774829) 2013, Springer Science+Business Media, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
100%: Sous la direction de: Gerhard Jakse, Sous la direction de: C. Bouffioux, Sous la direction de: J. de Leval, Sous la direction de: R.A. Janknegt: Benign Prostatic Hyperplasia: Conservative and Operative Management (ISBN: 9783540554240) 1992, Springer Verlag, 1992., in Deutsch.Nur diese Ausgabe anzeigen…
100%: Gerhard Jakse; Christian Bouffioux; Jean de Leval; Rudi A. Janknegt: Benign Prostatic Hyperplasia : Conservative and Operative Management (ISBN: 9783642774805) in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
71%: G. Jakse; Bouffioux C.; Deleval J.; Editor-Ruud A. Janknegt: Benign Prostatic Hyperplasia Conservative and Operative Management 1993 Paperback (ISBN: 9780387554242) 1993, in Englisch.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
Benign Prostatic Hyperplasia: Conservative and Operative Management
13 Angebote vergleichen
| Preise | 2014 | 2015 | 2017 |
|---|---|---|---|
| Schnitt | € 85,67 | € 106,82 | € 96,86 |
| Nachfrage |
1
Benign Prostatic Hyperplasia
DE PB NWISBN: 9783642774829 bzw. 3642774822, in Deutsch, Springer, Berlin, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
buecher.de GmbH & Co. KG, [1].
An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or operative means. This entails an immense social and economic impact in terms of health costs. In addition, recent data indicate the most frequently performed operation for BPH - transurethral resection of the prostate - is associated with a higher risk of death due to cardiac disease than open prostatectomy. Furthermore, studies using the recently developed technique of uro dynamics to assess bladder outflow obstruction reveal that about 20% -30% of patients treated with transurethral resection or open prostatectomy are actually not obstructed. This means that these patients do not receive the most effective therapy. Finally, various new treatment been developed, including medical treat modalities have ment directed at endocrine pathways in the prostatic cells, balloon dilatation, spirals, temporary or permanent stents, C). nd the application of heat in hyperthermia or thermo therapy. The contributions to this volume were selected from a symposium on the diagnosis and treatment of BPH. They are intended to provide a comprehensive review of the state of the art in treating BPH. Aachen, Liege, Maastricht, September 1992 The Editors Contents Development of Benign Prostatic Hyperplasia 1 J. E. Altwein and H. Baur Bladder Outflow Obstruction: Definition, Clinical Application, and Grading in Benign Prostatic Hyperplasia. . . . . . .Softcover reprint of the original 1st ed. 1992. 2013. xi, 198 S. 55 SW-Abb., 31 Tabellen. 235 mmVersandfertig in 3-5 Tagen, Softcover.
buecher.de GmbH & Co. KG, [1].
An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or operative means. This entails an immense social and economic impact in terms of health costs. In addition, recent data indicate the most frequently performed operation for BPH - transurethral resection of the prostate - is associated with a higher risk of death due to cardiac disease than open prostatectomy. Furthermore, studies using the recently developed technique of uro dynamics to assess bladder outflow obstruction reveal that about 20% -30% of patients treated with transurethral resection or open prostatectomy are actually not obstructed. This means that these patients do not receive the most effective therapy. Finally, various new treatment been developed, including medical treat modalities have ment directed at endocrine pathways in the prostatic cells, balloon dilatation, spirals, temporary or permanent stents, C). nd the application of heat in hyperthermia or thermo therapy. The contributions to this volume were selected from a symposium on the diagnosis and treatment of BPH. They are intended to provide a comprehensive review of the state of the art in treating BPH. Aachen, Liege, Maastricht, September 1992 The Editors Contents Development of Benign Prostatic Hyperplasia 1 J. E. Altwein and H. Baur Bladder Outflow Obstruction: Definition, Clinical Application, and Grading in Benign Prostatic Hyperplasia. . . . . . .Softcover reprint of the original 1st ed. 1992. 2013. xi, 198 S. 55 SW-Abb., 31 Tabellen. 235 mmVersandfertig in 3-5 Tagen, Softcover.
2
Benign Prostatic Hyperplasia (2013)
DE PB NWISBN: 9783642774829 bzw. 3642774822, in Deutsch, Springer, Taschenbuch, neu.
Lieferung aus: Schweiz, Versandfertig innert 6 - 9 Tagen.
Conservative and Operative Management, An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or operative means. This entails an immense social and economic impact in terms of health costs. In addition, recent data indicate the most frequently performed operation for BPH - transurethral resection of the prostate - is associated with a higher risk of death due to cardiac disease than open prostatectomy. Furthermore, studies using the recently developed technique of uro dynamics to assess bladder outflow obstruction reveal that about 20% -30% of patients treated with transurethral resection or open prostatectomy are actually not obstructed. This means that these patients do not receive the most effective therapy. Finally, various new treatment been developed, including medical treat modalities have ment directed at endocrine pathways in the prostatic cells, balloon dilatation, spirals, temporary or permanent stents, C). nd the application of heat in hyperthermia or thermo therapy. The contributions to this volume were selected from a symposium on the diagnosis and treatment of BPH. They are intended to provide a comprehensive review of the state of the art in treating BPH. Aachen, Liege, Maastricht, September 1992 The Editors Contents Development of Benign Prostatic Hyperplasia 1 J. E. Altwein and H. Baur Bladder Outflow Obstruction: Definition, Clinical Application, and Grading in Benign Prostatic Hyperplasia. . . . . . . Taschenbuch, 03.10.2013.
Conservative and Operative Management, An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or operative means. This entails an immense social and economic impact in terms of health costs. In addition, recent data indicate the most frequently performed operation for BPH - transurethral resection of the prostate - is associated with a higher risk of death due to cardiac disease than open prostatectomy. Furthermore, studies using the recently developed technique of uro dynamics to assess bladder outflow obstruction reveal that about 20% -30% of patients treated with transurethral resection or open prostatectomy are actually not obstructed. This means that these patients do not receive the most effective therapy. Finally, various new treatment been developed, including medical treat modalities have ment directed at endocrine pathways in the prostatic cells, balloon dilatation, spirals, temporary or permanent stents, C). nd the application of heat in hyperthermia or thermo therapy. The contributions to this volume were selected from a symposium on the diagnosis and treatment of BPH. They are intended to provide a comprehensive review of the state of the art in treating BPH. Aachen, Liege, Maastricht, September 1992 The Editors Contents Development of Benign Prostatic Hyperplasia 1 J. E. Altwein and H. Baur Bladder Outflow Obstruction: Definition, Clinical Application, and Grading in Benign Prostatic Hyperplasia. . . . . . . Taschenbuch, 03.10.2013.
3
Benign Prostatic Hyperplasia
DE PB NWISBN: 9783642774829 bzw. 3642774822, in Deutsch, Springer, Taschenbuch, neu.
Lieferung aus: Schweiz, 03.10.2013.
Conservative and Operative Management, An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or operative means. This entails an immense social and economic impact in terms of health costs. In addition, recent data indicate the most frequently performed operation for BPH - transurethral resection of the prostate - is associated with a higher risk of death due to cardiac disease than open prostatectomy. Furthermore, studies using the recently developed technique of uro dynamics to assess bladder outflow obstruction reveal that about 20% -30% of patients treated with transurethral resection or open prostatectomy are actually not obstructed. This means that these patients do not receive the most effective therapy. Finally, various new treatment been developed, including medical treat modalities have ment directed at endocrine pathways in the prostatic cells, balloon dilatation, spirals, temporary or permanent stents, C). nd the application of heat in hyperthermia or thermo therapy. The contributions to this volume were selected from a symposium on the diagnosis and treatment of BPH. They are intended to provide a comprehensive review of the state of the art in treating BPH. Aachen, Liege, Maastricht, September 1992 The Editors Contents Development of Benign Prostatic Hyperplasia 1 J. E. Altwein and H. Baur Bladder Outflow Obstruction: Definition, Clinical Application, and Grading in Benign Prostatic Hyperplasia. . . . . . .
Conservative and Operative Management, An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or operative means. This entails an immense social and economic impact in terms of health costs. In addition, recent data indicate the most frequently performed operation for BPH - transurethral resection of the prostate - is associated with a higher risk of death due to cardiac disease than open prostatectomy. Furthermore, studies using the recently developed technique of uro dynamics to assess bladder outflow obstruction reveal that about 20% -30% of patients treated with transurethral resection or open prostatectomy are actually not obstructed. This means that these patients do not receive the most effective therapy. Finally, various new treatment been developed, including medical treat modalities have ment directed at endocrine pathways in the prostatic cells, balloon dilatation, spirals, temporary or permanent stents, C). nd the application of heat in hyperthermia or thermo therapy. The contributions to this volume were selected from a symposium on the diagnosis and treatment of BPH. They are intended to provide a comprehensive review of the state of the art in treating BPH. Aachen, Liege, Maastricht, September 1992 The Editors Contents Development of Benign Prostatic Hyperplasia 1 J. E. Altwein and H. Baur Bladder Outflow Obstruction: Definition, Clinical Application, and Grading in Benign Prostatic Hyperplasia. . . . . . .
4
Benign Prostatic Hyperplasia. Conservative and Operative Management (1992)
DEISBN: 9783540554240 bzw. 3540554246, in Deutsch, Springer Verlag.
Von Händler/Antiquariat, adamsbuch Einzelunternehmen [53244508], Heinsberg, Germany.
198 Seiten Keinerlei Einträge, sehr guter Zustand. Sprache: en Gewicht in Gramm: 333.
198 Seiten Keinerlei Einträge, sehr guter Zustand. Sprache: en Gewicht in Gramm: 333.
5
Benign Prostatic Hyperplasia. Conservative and Operative Management
DE USISBN: 3540554246 bzw. 9783540554240, in Deutsch, Springer Verlag, 1992. gebraucht.
Lieferung aus: Deutschland, Versandart: STD, Versand nach: DE.
Von Händler/Antiquariat, adamsbuch Einzelunternehmen, [2906].
Keinerlei Einträge, sehr guter Zustand. 198 Seiten Gr.-8°, Hardcover/Pappeinband.
Von Händler/Antiquariat, adamsbuch Einzelunternehmen, [2906].
Keinerlei Einträge, sehr guter Zustand. 198 Seiten Gr.-8°, Hardcover/Pappeinband.
7
Benign Prostatic Hyperplasia: Conservative and Operative Management (2013)
EN PB NW RPISBN: 9783642774829 bzw. 3642774822, in Englisch, 216 Seiten, Springer, Taschenbuch, neu, Nachdruck.
Neu ab: € 84,30 (7 Angebote)
Gebraucht ab: € 72,80 (3 Angebote)
Zu den weiteren 10 Angeboten bei Amazon.de (Int.)
Lieferung aus: Deutschland, Versandfertig in 4 - 5 Werktagen, Versandkostenfrei.
Von Händler/Antiquariat, averdo24.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, averdo24.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Benign Prostatic Hyperplasia
DE NW EBISBN: 9783642774805 bzw. 3642774806, in Deutsch, Springer Nature, neu, E-Book.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Lagernd.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Benign Prostatic Hyperplasia
DE NWISBN: 9783642774829 bzw. 3642774822, in Deutsch, Springer Science+Business Media, neu.
Lieferung aus: Deutschland, Lagernd.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…